Cleared Traditional

K171446 - Cefaly Acute (FDA 510(k) Clearance)

Sep 2017
Decision
122d
Days
Class 2
Risk

K171446 is an FDA 510(k) clearance for the Cefaly Acute. This device is classified as a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II - Special Controls, product code PCC).

Submitted by Cefaly Technology (Seraing, BE). The FDA issued a Cleared decision on September 15, 2017, 122 days after receiving the submission on May 16, 2017.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5891. Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin..

Submission Details

510(k) Number K171446 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 2017
Decision Date September 15, 2017
Days to Decision 122 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PCC - Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.